Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA
David T. Rubin, MD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
The Evolving Role of Small Molecules in IBD Care
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Navigating IBD Guidelines: What Clinicians Need to Know Now
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
Beyond Biology: Environmental and Lifestyle Influences in IBD
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Pathophysiology of IBD: The War Within
Understanding the Microbiome’s Role in IBD Management
Targeting Inflammation in IBD: Localized vs Systemic Strategies
IBD Beyond Symptoms: What Community GIs Need to Know
Remission: Can You Prove It?
David Rubin, MD
Kimberly D. Orleck, PA-C
Switching Strategies: Switch or Stay—What’s Your Call?
Brooke Hodnick, PA-C, MPAS
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.